Tag: stem cell market data

  • Comprehensive Stem Cell Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Stem Cell Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Rate Can Be Expected in the Stem Cell Market from 2024 Through 2033?

    The size of the stem cell market has been on a robust growth trajectory in recent periods. It is projected to expand from $13.97 billion in 2023 to $15.34 billion in 2024, reflecting a compound annual growth rate (CAGR) of 9.8%. Factors such as advancements in regenerative medicine, increasing chronic disease prevalence, research and development efforts, a growing elderly population, and heightened awareness and acceptance can explain the significant growth experienced during the historical period.

    In the coming years, the size of the stem cell market is anticipated to experience rapid expansion. The projection suggests it will reach $23.13 billion in 2028, exhibiting a compound annual growth rate (CAGR) of 10.8%. The growth projected for this period can be accredited to the increased usage in oncology, novel advancements in individualized medicine, governmental backing and funding, partnerships and collaborations in biotechnology, clinical trials, as well as regulatory green lights. The forecasted period will likely witness trends such as the commercial use of stem cell therapies, the use of crispr technology, the enhancement of regulatory frameworks, investment into stem cell research, and a shift towards exosome therapeutic approaches.

    Claim Your Free Sample of the Global Stem Cell Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2584&type=smp

    What Dynamics Are Shaping the Growth of the stem cell Market?

    The prolific rise in Chronic diseases globally is bolstering the Stem cell market. The method of using stem cells to address or prevent a condition or disease is known as stem-cell therapy. Bone marrow transplants are the most commonly practiced stem-cell therapy, although there are therapies using umbilical cord blood also in application. Presently, the transplantation of blood stem cells to treat blood and immune system diseases and conditions, or to rebuild the blood system after specific cancer treatments, is prevalent. In light of the projections by the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, in January 2023, the worldwide count of people suffering from chronic diseases is projected to inflate to 142.66 million by 2050, from 71.522 million in 2020.

    What Are the Essential Segments of the Stem Cell Market?

    1) By Source: Autologous, Allogeneic

    2) By Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Other Products

    3) By Application: Regenerative Medicine, Drug Discovery And Development

    What Are the Defining Trends in the Evolving Stem Cell Market?

    Order Now for Fast Delivery of Your Stem Cell Market Report!

    https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

    Which Regions Are Emerging as Leaders in the Stem Cell Market?

    North America was the largest region in the stem cell market in 2023. Western Europe was the second largest region in the global stem cell market share. The regions covered in the stem cell market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Stem Cell Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the stem cell market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Stem Cell Market Include

    1. Stem Cell Market Executive Summary

    2. Stem Cell Market Segments

    3. Stem Cell Market Size And Template Market Growth Rate

    4. Key Stem Cell Market Trends

    5. Major Stem Cell Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Stem Cell Market

    26. Top Stem Cell Companies

    27. Stem Cell Market Opportunities And Strategies

    28. Stem Cell Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Interventional Neurology Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/interventional-neurology-devices-and-equipment-global-market-report

    Neurostimulation Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

    Neuroprosthetics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neuroprosthetics-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis On Size, Share, And Drivers Of The Stem Cell Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Stem Cell Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Rapid Market Growth

    • Current Market Size: Grew from $13.97 billion in 2023 to $15.34 billion in 2024.
    • Growth Rate: Compound annual growth rate (CAGR) of 9.8%.
    • Key Drivers:
      • Advancements in regenerative medicine.
      • Rising prevalence of chronic diseases.
      • Increased research and development initiatives.
      • Growing aging population.
      • Enhanced awareness and acceptance.

    Forecasted Market Expansion

    • Future Projections: Expected to grow to $23.13 billion by 2028.
    • Growth Rate: CAGR of 10.8%.
    • Growth Factors:
      • Expanding applications in oncology.
      • Innovations in personalized medicine.
      • Government support and funding.
      • Biotechnology collaborations and partnerships.
      • Clinical trials and regulatory approvals.

    View More On The Stem Cell Market Report 2024 – https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

    Major Trends in the Forecast Period

    • Commercialization of Stem Cell Therapies: Increasing market availability.
    • CRISPR Technology: Enhanced precision in genetic modifications.
    • Regulatory Framework Development: Establishing guidelines for safety and efficacy.
    • Investments in Stem Cell Research: Boosting technological advancements.
    • Exosome Therapeutics: Emerging as a new focus area.

    The Impact of Chronic Diseases

    • Prevalence: Increasing number of chronic diseases worldwide.
    • Stem Cell Therapy Applications:
      • Treat or prevent diseases.
      • Widely used in bone marrow transplants and umbilical cord blood-derived therapies.
      • Blood stem cell transplantation for blood and immune system disorders and post-cancer treatment recovery.
    • Projected Increase: From 71.522 million people in 2020 to 142.66 million by 2050.

    Key Players in the Market

    • Leading Companies:
      • Danaher Corporation
      • Cryo-Cell International Inc.
      • Daiichi Sankyo Company Limited
      • Lonza Group Ltd.
      • PerkinElmer Inc.
      • CellGenix GmbH
      • China Cord Blood Corporation
      • Organogenesis Holdings Inc.
      • LifeCell International
      • AMAG Pharmaceuticals Inc.
      • Many more.

    Advancements in iPSC Technology

    • Induced Pluripotent Stem Cells (iPSC):
      • Derived from reprogrammed blood or skin cells.
      • Embryonic-like pluripotent state.
      • Ethical advantage: Not derived from human embryos.
    • Notable Developments:
      • Japanese company Oksara’s iPS cell center.
      • Takara Bio’s Cellartis for disease modeling and drug discovery.

    Strategic Acquisitions

    • Catalent’s Acquisition of Rheincell Therapeutics GmbH:
      • Date: August 2021.
      • Purpose: To enhance Catalent’s cell therapy portfolio.
      • Outcome: Offering iPSC banks as a premium source for therapeutic development.
      • Rheincell Therapeutics GmbH: Specializes in GMP-compliant generation of human iPS cells.

    Market Segmentation

    • By Source:
      • Autologous (self-derived)
      • Allogeneic (donor-derived)
    • By Product Type:
      • Adult Stem Cells
      • Human Embryonic Stem Cells
      • Induced Pluripotent Stem Cells
      • Other Products
    • By Application:
      • Regenerative Medicine
      • Drug Discovery and Development

    Regional Insights

    • North America: Largest market in 2023, driven by advanced healthcare infrastructure and significant research investments.

    The stem cell market is witnessing robust growth driven by technological advancements, expanding applications, and increased funding. The future looks promising with continued innovation and strategic partnerships, positioning the market for significant advancements in healthcare and therapeutic solutions.

    Request A Sample Of The Global Stem Cell Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=2584&type=smp